3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Pregnancy is the period from conception to birth. A pregnancy may be complicated by health problems or lifestyle issues known as risk factors. These risk factors can affect the mother or fetus, or both


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Diabetes -

Corporate Toronto rides hard for diabetes research

DiabetesSep 25, 05

More than 5,000 people, made up of employees from some of Canada’s top corporations, put their pedal to the metal today in support of the 2005 Ride for Diabetes Research held at Nathan Phillips Square to raise money for the Juvenile Diabetes Research Foundation (JDRF).

In its 17th year, the Ride for Diabetes Research is a unique fundraising event where each of five members of a corporate team rides a stationary bike in eight-minute intervals within an hour. Last year, the Ride for Diabetes Research raised nearly $1.2 million. This year, Ride participants are on track to surpass that figure and raise $1.4 million.

A “Battle of the Banks” will take place at noon with executive teams from each of the financial institutions competing against one another to clock the most kilometres and raise the most funds. This year’s results will be announced once all pledges are in and the cup will be awarded to the winner.

As always, the majority of companies participating come from the financial and legal sectors and all want to help in the fight against a disease that strikes children. Key participating companies include TSX Group, Aird & Berlis LLP, TD Bank Financial Group, RBC Financial Group and Scotiabank. Several have been contributors to the Ride since its inception, with employee teams raising from $500 to $20,000.
“The Ride for Diabetes Research is a high-impact, energetic event that brings people together to make a difference,” says Matt Varey, head of Career Sales Force, RBC Financial Group. “Participants get so excited and pumped up for this event and a little friendly rivalry between the teams never hurts, especially when raising money for such an important cause like Juvenile Diabetes.”

The funds raised go toward JDRF’s world-renowned research program, which has produced major scientific breakthroughs in the search for a cure for juvenile (type 1) diabetes, including islet cell transplantation and stem cell research.

“We need to fuel the momentum of diabetes research which has led us so close to finding a cure for this disease,” says Ron Forbes, President and CEO of the Juvenile Diabetes Research Foundation. “JDRF depends on the generous support of the riders and corporate sponsors to help us get to the next crucial stage of research.”

Juvenile diabetes is the most severe form of diabetes, which mainly strikes infants, children, and young adults, leaving them dependant on daily insulin injections. It is a disease that one does not outgrow and those living with diabetes are faced with serious complications, including Blindness, nerve damage, heart disease, stroke, kidney failure, and limb amputation.

The Juvenile Diabetes Research Foundation is the leading non-profit, non-governmental funder and advocate of diabetes research in Canada and the world. JDRF’s mission is to find a cure for diabetes and its complications through the support of research. In 2005, JDRF Canada will give over $10 million to diabetes research. Since its inception in 1974, JDRF has provided more than $1 billion in direct funding to diabetes research worldwide.

For more information on JDRF and the Ride for Diabetes Research, call 905-944-8700 or visit the website at http://www.jdrf.ca.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Study Sheds Light on Participants in National SEARCH for Diabetes in Youth Study
  Pregnancy diabetes doubles the risk of language delay in children
  Clinical Guideline on Prevention of Cardiovascular Disease and Diabetes in Patients at Highest Risk
  Obesity, other health problems delay MS diagnosis
  If the diabetes has a direct carcinogenetic effect?
  Cost of diabetes treatment escalating in US
  Moderate Use Averts Failure of Type 2 Diabetes Drugs in Animal Model
  Moderate Use May Avert Failure of Type 2 Diabetes Drugs
  Fasting may cut risks of heart disease, diabetes
  Vision loss more common in people with diabetes
  New Target for Obesity-Related Insulin Resistance, Type 2 Diabetes
  People with Type 2 Diabetes Can Put Fatty Livers on a Diet with Moderate Exercise

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site